The Evolutionary Tale and Future Directions of Aromatase Inhibitors in Breast Carcinoma

E-ISSN： 1875-5992|17|11|1487-1499

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.17, Iss.11, 2017-11, pp. : 1487-1499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase Inhibitors for Treatment of Breast Cancer

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 67-79

Bentham Science Publishers

Access to resources Recommend Favorite

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

By Jonat Walter Hilpert Felix

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 6, 2006-06 ,pp. : 343-355

Springer Publishing Company

Access to resources Recommend Favorite

Postmenopausal breast cancer, androgens, and aromatase inhibitors

By Campagnoli C.

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase Inhibitors: Indications for Breast Cancer Therapy

By Assikis V.J.

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 93-100

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors in the treatment of early and advanced breast cancer

By Joensuu Heikki Ejlertsen Bent Lønning Per Rutqvist Lars-Erik

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite